This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Tax treatment influences index fund performance in IRAs. This guide breaks down how Roth and traditional IRAs compare in real‑world scenarios.
28,321 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Ally Financial is off to a challenging start in 2026, with shares down as inflation and tariff risks bite auto lendin...
Shareholders allege Nvidia hid how much crypto miners boosted gaming GPU sales. The case could reshape disclosures ac...
Netcapital announces a nonbinding LOI to buy Resmac’s mortgage assets from RezyFi in a $5 million all-stock transacti...
Nike delivered a quarterly beat that sent its shares higher, but investors kept a close eye on tariffs and future gui...
A new analysis challenges Dave Ramsey’s Social Security guidance, arguing that claiming at 62 can reduce lifetime ben...
A fresh wave of legal headlines rattled the markets, pulling down a big‑name hardware stock and lifting caution acros...
Akron is weighing a plan to remove minimum lot size rules to unlock hundreds of vacant parcels and accelerate infill ...
CryptoQuant data shows the altcoin market reaches extreme weakness, with 40% of tokens trading near all-time lows as ...
Pi Network’s PI surged to a 3-month high near $0.23 as Bitcoin hovered around $68,000 this weekend, marking a rare br...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
Apple rolled out a beta Siri upgrade with limited regional access, keeping EU and China on the sidelines. Investors a...